Venous thromboembolism and bleeding in critically ill patients with severe renal insufficiency receiving dalteparin thromboprophylaxis: Prevalence, incidence and risk factors

Critical Care

Volumn 12, Issue 2, 2008, Pages

  Cook, Deborah ^a   Douketis, James ^a   Meade, Maureen ^a   Guyatt, Gordon ^a   Zytaruk, Nicole ^a   Granton, John ^b   Skrobik, Yoanna ^c   Albert, Martin ^c   Fowler, Robert ^b   Hebert, Paul ^d   Pagliarello, Guiseppe ^d   Friedrich, Jan ^b   Freitag, Andreas ^a   Karachi, Tim ^a   Rabbat, Christian ^a   Heels Ansdell, Diane ^a   Geerts, William ^b   Crowther, Mark ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

^d UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BLOOD CLOTTING FACTOR 10A INHIBITOR; DALTEPARIN; HEPARIN; ANTICOAGULANT AGENT;

ACUTE KIDNEY FAILURE; ADULT; AGED; ANTICOAGULANT THERAPY; APACHE; ARTICLE; BLEEDING; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; COHORT ANALYSIS; COMORBIDITY; CREATININE CLEARANCE; CRITICALLY ILL PATIENT; DEEP VEIN THROMBOSIS; DIALYSIS; DRUG USE; ECHOGRAPHY; FEMALE; HUMAN; INCIDENCE; INTENSIVE CARE UNIT; INTERNATIONAL NORMALIZED RATIO; KIDNEY FAILURE; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OPEN STUDY; PREVALENCE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; REGRESSION ANALYSIS; RISK FACTOR; SCORING SYSTEM; SCREENING TEST; VENOUS THROMBOEMBOLISM; CHEMICALLY INDUCED DISORDER; CRITICAL ILLNESS; LEG; RENAL REPLACEMENT THERAPY; VASCULARIZATION; VEIN THROMBOSIS;

AGED; ANTICOAGULANTS; APACHE; CRITICAL ILLNESS; DALTEPARIN; FEMALE; HEMORRHAGE; HUMANS; INCIDENCE; INTERNATIONAL NORMALIZED RATIO; LEG; MALE; PREVALENCE; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; PULMONARY EMBOLISM; RENAL DIALYSIS; RENAL INSUFFICIENCY; RISK FACTORS; VENOUS THROMBOSIS;

EID: 41849083777     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc6810     Document Type: Article

References (30)

1. Cook D Crowther M Meade M Rabbat C Griffith L Schiff D Geerts W Guyatt G Deep venous thrombosis in medical-surgical critically ill patients: prevalence, incidence, and risk factors Crit Care Med 2005, 33:1565-1571. 10.1097/01.CCM.0000171207.95319.B2 16003063
2. Attia J Ray JG Cook DJ Douketis J Ginsberg JS Geerts WH Deep vein thrombosis and its prevention in critically ill adults Arch Intern Med 2001, 161:1268-1279. 10.1001/archinte.161.10.1268 11371254
3. Hirsch DR Ingenito EP Goldhaber SZ Prevalence of deep venous thrombosis among patients in medical intensive care JAMA 1995, 274:335-337. 10.1001/ jama.274.4.335 7609264
4. Irish AB Green FR Factor VII coagulant activity (VIIc) and hypercoagulability in chronic renal disease and dialysis: Relationship with dyslipidaemia, inflammation, and factor VII genotype Nephrol Dial Transplant 1998, 13:679-684. 10.1093/ndt/13.3.679 9550647
5. Tveit DP Hypolite IO Hshieh P Cruess D Agodoa L Welch PG Abbot KC Chronic dialysis patients have high risk for pulmonary embolism Am J Kidney Dis 2002, 39:1011-1017. 10.1053/ajkd.2002.32774 11979344
6. Wun T Law L Harvey D Sieracki B Scudder SA Ryu JK Increased incidence of symptomatic venous thrombosis in patients with cervical carcinoma treated with concurrent chemotherapy, radiation, and erythropoietin Cancer 2003, 98:1514-1520. 10.1002/cncr.11700 14508840
7. Steurer M Sudmeier I Stauder R Gastl G Thromboembolic events in patients with myelodysplastic syndrome receiving thalidomide in combination with darbepoietin-alpha Br J Haematol 2003, 121:101-103. 10.1046/ j.1365-2141.2003.04252.x 12670338
8. Weitz JI Low molecular weight heparins N Engl J Med 1997, 337:688-699. 10.1056/NEJM199709043371007 9278467
9. Ravaud P Durieux P Fourcade A the Comite Scientifique Thrombose AP-HP Prophylaxie des thromboses veineuses post-operatoires: Recommendations de L'assistance publique des hopitaux de Paris Sangue Thromb Vaisseaux 1995, 7:119-129.
10. Zytaruk N Douketis J Meade M Crowther M Guyatt G Geerts W Anderson D Skrobik Y Albert M Hebert P Pagliarello G Granton J Fowler R Freitag A Karachi T Rabbat C Mehta S Rocker G Poirier G Marshall J Cook D DIRECT Investigators for the Canadian Critical Care Trials Group Dalteparin's influeTce on the renally compromised: Anti-ten-a: the DIRECT study Am Rev Respir Crit Care Med 2006, 3:A738c.
11. Cockroft DW Gault MH Prediction of creatinine clearance from serum creatinine Nephron 1976, 16:31-41. 1244564
12. Cook DJ Medic A Andrews J Schiff D Dobranowski J Bates S McDonald E Landry F Crowther MA Doppler compression ultrasound of the lower extremities in ICU patients: An inter-rater reliability study Crit Care Med 2003, A346.
13. Kearon C Julian JA Newman TE Ginsberg JS Noninvasive diagnosis of deep venous thrombosis. McMaster Diagnostic Imaging Practice Guidelines Initiative Ann Intern Med 1998, 128:663-677. 9537941
14. PIOPED Investigators Value of ventilation/perfusion scan in acute pulmonary embolism. Results of the prospective investigation of pulmonary embolism diagnosis (PIOPED) JAMA 1990, 263:2753-2759. 10.1001/ jama.263.20.2753 2332918
15. Remy-Jardin M Remy J Deschildre F Artaud D Beregi JP Hossein-Foucher C Marchandise X Duhamel A Diagnosis of pulmonary embolism with spiral CT: comparison with pulmonary angiography and scintigraphy Radiology 1996, 200:699-706. 8756918
16. Arnold DM Donahoe L Clarke FJ Tkaczyk AJ Heels-Ansdell D Zytaruk N Cook RJ Webert KE McDonald E Cook DJ Bleeding during critical illness: A prospective cohort study using a new measurement tool Clin Invest Med 2007, 30:E93-E102. 17716547
17. Laposata M Green D Van Cott EM Barrowcliffe TW Goodnight SH Sosolik RC College of American Pathologists conference XXXI on laboratory monitoring of anticoagulant therapy Arch Pathol Lab Med 1998, 122:799-807. 9740137
18. Hirsh J Warkentin TE Shaughnessy SG Anand SS Halperin JL Raschke R Granger C Ohman EM Dalen JE Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety Chest 2001, 119:64S-94S. 10.1378/chest.119.1_suppl.64S 11157643
19. Knaus WA Draper EA Wagner DP Zimmerman JE APACHE II: A severity of disease classification system Crit Care Med 1985, 16:818-819.
20. Levine MN Planes A Hirsh J Goodyear M Vochelle N Gent M The relationship between anti-factor Xa level and clinical outcome in patients receiving enoxaparine low molecular weight heparin to prevent deep vein thrombosis after hip replacement Thromb Haemost 1989, 62:940-944. 2556813
21. Mahe I Aghassarian M Drouet L dit-Sollier CB Lacut K Heilmann JJ Mottier D Bergmann JF Tinzaparin and enoxaparin given at prophylactic dose for eight days in medical elderly patients with impaired renal function: A comparative pharmacokinetic study Thromb Haemost 2007, 97:581-586. 17393021
22. Rabbat C Cook DJ Crowther MA McDonald E Clarke F Meade MO Lee KA Cook RJ Dalteparin thromboprophylaxis for critically ill medical-surgical patients J Crit Care 2005, 20:357-363. 10.1016/j.jcrc.2005.09.009 16310608
23. Lim W Cook DJ Crowther MA Safety and efficacy of low molecular weight heparins for hemodialysis in patients with end-stage renal failure: A meta-analysis of randomized trials J Am Soc Nephrol 2004, 15:3192-3206. 10.1097/01.ASN.0000145014.80714.35 15579523
24. Koreth R Weinert C Weisdorf DJ Key NS Measurement of bleeding severity: a critical review Transfusion 2004, 44:605-617. 10.1111/ j.1537-2995.2004.03153.x 15043580
25. Raskob G Kearon C Geerts W Planes A Eriksson B Paiement G Lassen M Bergqvist D Turpie G Agnelli G Buller H Hirsh J Evaluating bleeding complications of thromboprophylaxis after hip replacement: A systematic review J Thromb Haemost 2003, 1:1860. 10.1046/j.1538-7836.2003.00355.x
26. Kani C Markantonis SL Nicolaou C Maggina N Monitoring of subcutaneous dalteparin in patients with renal insufficiency under intensive care: An observational study J Crit Care 2006, 21:79-84. 10.1016/ j.jcrc.2005.09.056 16616629
27. Tencani E Mannucci C Casolari B Turrini F Crowther MA Prisco D Cenci AM Bondi M Safety of dalteparin for the prophylaxis of venous thromboembolism in elderly medical patients with renal insufficiency: A pilot study Haematologica 2006, 97:976-979.
28. Ibrahim EH Iregui M Prentice D Sherman G Kollef M Shannon W Deep vein thrombosis during prolonged mechanical ventilation despite prophylaxis Crit Care Med 2002, 30:771-774. 10.1097/00003246-200204000-00008 11940743
29. Merrer J De Jonghe B Golliot F Lefrant JY Raffy B Barre E Rigaud JP Casciani D Misset B Bosquet C Outin H Brun-Buisson C Nitenberg G for the French Catheter Study Group in Intensive Care Complications of femoral and subclavian venous catheterization in critically ill patients: A randomized controlled trial JAMA 2001, 286:700-707. 10.1001/ jama.286.6.700 11495620
30. Cook DJ Rocker G Meade MO Guyatt GH Geerts W Anderson D Skrobik Y Hebert P Albert M Cooper J Bates S Caco C Finfer S Fowler R Freitag A Granton J Jones G Langevin S Mehta S Pagliarello G Poirier G Rabbat C Schiff D Griffith L Crowther M for the PROTECT Investigators and the Canadian Critical Care Trials Group Prophylaxis of Thromboembolism in Critical Care (PROTECT) Trial: A pilot study J Crit Care 2005, 20:364-372. 10.1016/j.jcrc.2005.09.010 16310609